No takes yet. Share an insight, caveat, or question.
Cell-based screening demonstrates robust multiplex gene knockout and synthetic lethal mapping in cancer cells, highlighting reduced assay costs.
Anvar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: